Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
about
QSAR modeling: where have you been? Where are you going to?Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compoundsPredicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches.Short communication: cheminformatics analysis to identify predictors of antiviral drug penetration into the female genital tractPredicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitizationQSAR analysis of the toxicity of nitroaromatics in Tetrahymena pyriformis: structural factors and possible modes of action.Modern approaches to accelerate discovery of new antischistosomal drugs.Chemical toxicity prediction for major classes of industrial chemicals: Is it possible to develop universal models covering cosmetics, drugs, and pesticides?Existing and Developing Approaches for QSAR Analysis of Mixtures.Chalcone Derivatives: Promising Starting Points for Drug Design.Universal Approach for Structural Interpretation of QSAR/QSPR Models.QSPR Approach to Predict Nonadditive Properties of Mixtures. Application to Bubble Point Temperatures of Binary Mixtures of Liquids.QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.Alarms about structural alerts.Predicting binding affinity of CSAR ligands using both structure-based and ligand-based approaches.Interpretation of QSAR Models Based on Random Forest Methods.QSAR Modeling of Tox21 Challenge Stress Response and Nuclear Receptor Signaling Toxicity Assays
P2860
Q28222668-802D8495-212B-4970-8E12-B3CED2817C35Q28386501-41035227-7771-47A8-8E83-0BE4F5104CFDQ31019492-0B67512F-EFE6-4522-A1C8-442F9C45FAADQ34399668-EA29AFF2-BC21-4737-82B8-0EB3A69370FBQ35533343-E9A65138-9C26-488F-BCAF-59C716D19CEFQ36233484-C7BFEDDE-EB47-4356-B887-C460B56DE7B6Q38807251-30C28485-4AFE-4DA0-BDCB-D01D8DE85428Q38835541-08D5F353-5BE2-4EA5-9BFE-CAFADCEE0A54Q38914231-18C7EF58-3E14-4045-9910-4955724CF681Q39027317-7BB61A6E-D7B4-4D29-B870-46BF15FE8079Q39537117-5199A7DC-8776-42E7-9502-523E733FD686Q39540069-10D378F9-A1A4-4E9A-9DAC-8E34CE82470AQ39768808-34ABE085-D089-469A-93DC-BB8A660242B3Q41881422-B1E3671F-053A-4BCD-9ECB-48BBABB58066Q42649336-F5EA4CF2-2216-4FA3-ACE8-707D18991D3DQ51563536-ACB72137-54A1-4146-A8DD-9D9774FCE4C9Q57898147-1D051F7D-E7CD-450C-91F1-25B5474CC6C5
P2860
Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
@en
Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
@nl
type
label
Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
@en
Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
@nl
prefLabel
Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
@en
Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
@nl
P2093
P2860
P356
P1476
Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
@en
P2093
Alla S Fedchuk
Anatoly G Artemenko
Angel S Galabov
Ekaterina V Varlamova
Eugene N Muratov
Ludmila S Koroleva
Michaela Schmidtke
Olga B Riabova
Pavel G Polischuk
Peter Wutzler
P2860
P304
P356
10.4155/FMC.10.194
P577
2010-07-01T00:00:00Z